Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Prevalentie van endoscopisch behandelbare laagrisicokanker bij LNPCP’s in het rechtercolon
jun 2025 | Endoscopie, Maag-darm-leveroncologie